MarketCap
Facebook
X
TelegramAnnual report 2023
added 03-22-2024
Recro Pharma EBITDA per Share 2011-2026 | REPH
Annual EBITDA per Share Recro Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.13 | 0.16 | -0.1 | 1.26 | -2.09 | -1.3 | -1.29 | -0.165 | -1.9 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.26 | -2.09 | -0.524 |
Quarterly EBITDA per Share Recro Pharma
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.02 | -0.01 | -0.01 | - | 0.01 | 0.01 | 0.02 | - | 0.1 | 0.12 | -0.05 | - | 0.17 | 0.02 | -0.05 | - | 0.52 | 0.55 | 0.27 | - | -0.56 | -0.56 | -0.57 | - | -0.46 | -0.4 | -0.29 | - | -0.19 | -0.51 | -0.34 | - | 0.14 | 0.21 | -0.53 | - | -0.61 | -0.36 | - | - | 0.01 | 0.01 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.55 | -0.61 | -0.108 |
EBITDA per Share of other stocks in the Drug manufacturers industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
0.27 | - | - | $ 142 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.16 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-0.86 | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
-0.89 | $ 1.27 | 6.72 % | $ 137 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
-1.16 | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
-0.504 | $ 2.67 | -0.19 % | $ 1.41 B | Canada |
 |
Agile Therapeutics
AGRX
|
-9.17 | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
-1.44 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
-1.4 | - | - | $ 50.1 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-10.3 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Eagle Pharmaceuticals
EGRX
|
6.31 | - | -39.89 % | $ 27.7 M | USA |
 |
HEXO Corp.
HEXO
|
-0.67 | - | 2.45 % | $ 38.1 M | Canada |
 |
Endo International plc
ENDP
|
1.3 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-2.22 | - | - | $ 36.6 M | USA |
 |
Emergent BioSolutions
EBS
|
-11.7 | $ 13.99 | 0.58 % | $ 716 M | USA |
 |
Athenex
ATNX
|
-10 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-0.42 | $ 21.43 | -0.33 % | $ 2.04 B |  France |
 |
Evolus
EOLS
|
-0.47 | $ 5.66 | 0.03 % | $ 351 M | USA |
 |
Harrow Health
HROW
|
0.05 | $ 50.22 | -1.54 % | $ 1.64 B | USA |
 |
China Pharma Holdings
CPHI
|
-0.11 | $ 1.58 | 17.04 % | $ 27.6 M |  China |
 |
Jupiter Wellness
JUPW
|
0.01 | - | - | $ 33.6 M | USA |
 |
OrganiGram Holdings
OGI
|
-0.36 | $ 1.72 | 2.08 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
6.1 | $ 7.89 | -0.25 % | $ 2.88 B | Canada |
 |
Pacira BioSciences
PCRX
|
0.12 | $ 26.1 | 0.38 % | $ 1.21 B | USA |
 |
Lannett Company
LCI
|
-3.52 | - | 1.15 % | $ 7.11 M | USA |
 |
Rockwell Medical
RMTI
|
-0.22 | $ 0.98 | 3.51 % | $ 22.9 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
0.22 | $ 4.88 | -5.97 % | $ 68.6 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-106 | - | - | $ 193 M | Canada |
 |
Sundial Growers
SNDL
|
-71 | $ 1.66 | 0.61 % | $ 3.37 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-2.88 | $ 3.78 | 0.27 % | $ 4.69 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.09 | $ 4.26 | -0.81 % | $ 561 M | USA |
 |
Aurora Cannabis
ACB
|
-1.67 | $ 4.29 | 1.06 % | $ 86.3 M | Canada |
 |
PetIQ
PETQ
|
2.8 | - | 1.64 % | $ 400 M | USA |
 |
Veru
VERU
|
-0.27 | $ 2.31 | -2.53 % | $ 312 M | USA |
 |
Perrigo Company plc
PRGO
|
3.19 | $ 14.83 | 1.61 % | $ 2.04 B | USA |
 |
ProPhase Labs
PRPH
|
1.79 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-1.13 | - | - | $ 1.42 B | USA |
 |
cbdMD
YCBD
|
-0.66 | $ 1.06 | -4.93 % | $ 4.57 M | USA |
 |
Relmada Therapeutics
RLMD
|
-3.45 | $ 4.31 | -0.35 % | $ 130 M | USA |
 |
OptiNose
OPTN
|
-0.2 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
-3.03 | $ 9.42 | -0.11 % | $ 669 M | USA |
 |
PLx Pharma
PLXP
|
-1.72 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-3.12 | $ 5.46 | -2.76 % | $ 223 M | USA |
 |
SCYNEXIS
SCYX
|
1.53 | $ 0.65 | 1.26 % | $ 31.1 M | USA |
 |
Tricida
TCDA
|
-2.97 | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
-2.22 | $ 9.12 | 1.39 % | $ 5.64 B | Canada |
 |
TherapeuticsMD
TXMD
|
-0.73 | $ 2.01 | -1.47 % | $ 21 M | USA |
 |
Viatris
VTRS
|
3.83 | $ 12.53 | 0.52 % | $ 15.2 B | USA |
 |
Zomedica Corp.
ZOM
|
-0.03 | - | -0.21 % | $ 98 M | USA |